%0
Generic
%T
Phase IIa Trial of Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) in Patients with Relapsed or Refractory CD19+ Lymphomas
%A Schuster, Stephen J.
%A Svoboda, Jakub
%A Dwivedy Nasta, Sunita
%A Porter, David L.
%A Chong, Elise A.
%A Mahnke, Yolanda
%A Lacey, Simon F.
%A Melenhorst, J. Joseph
%A Chew, Anne
%A Shah, Gaurav
%A Hasskarl, Jens
%A Litchman, Manuel
%A Wasik, Mariusz A.
%A Landsburg, Daniel J.
%A Mato, Anthony R.
%A Garfall, Alfred L.
%A Frey, Noelle V.
%A Marcucci, Katherine T.
%A Shea, Joanne
%A McConville, Holly
%A Zheng, Zhaohui
%A Levine, Bruce L.
%A June, Carl H.
%I American Society of Hematology
%@ 0006-4971
%@ 1528-0020
%D 2014
%C American Society of Hematology
%U http://slubdd.de/katalog?TN_libero_mab2